ATTR Amyloidosis
Neurology·MeSH: Amyloid Neuropathies, Familial
Prevalence
5.0 / 100K
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| NNC6019 | PROTHENA CORP PUBLIC LTD CO (PRTA) |
Frequently asked questions
How many drugs are in development for ATTR Amyloidosis?
BioSniper tracks 1 drug in development for ATTR Amyloidosis across 1 company.
How many clinical trials target ATTR Amyloidosis?
There are 3 clinical trials targeting ATTR Amyloidosis tracked by BioSniper.
What is the prevalence of ATTR Amyloidosis?
The estimated prevalence of ATTR Amyloidosis is approximately 5.0 per 100,000 population.
Deep-dive into ATTR Amyloidosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis